search
Back to results

Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury (NNP-UE+T)

Primary Purpose

Spinal Cord Injuries, Spinal Cord Injury at C5-C7 Level, Spinal Cord Injury Cervical

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Networked Neuroprosthetic System for Grasp and Trunk
Sponsored by
Kevin Kilgore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Neuroprosthesis, Functional Electrical Stimulation, Grasp, Posture, Standing, Function, Recovery, Device, Stimulation, Implant, Reach, Independence, Activities of Daily Living

Eligibility Criteria

17 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of cervical level spinal cord injury, either complete or incomplete; International Standards for Neurological Classification of Spinal Cord Injury (INCSCI) motor level of C4 through C8; American Spinal Injury Impairment Scale (AIS) grade A, B, C, or D; six months or more post-injury
  • Biceps/brachialis/brachioradialis strength of 2/5 or higher on Manual Muscle Test
  • Peripheral nerve innervation to upper extremity and trunk muscles, including a grade 3/5 or higher stimulated strength (Manual Muscle Test) in at least two of the following muscles in one arm: adductor pollicis, abductor pollicis brevis, flexor pollicis longus, extensor pollicis longus, extensor digitorum communis, flexor digitorum superficialis, flexor digitorum profundus, pronator quadratus, extensor carpi ulnaris, extensor carpi radialis brevis, extensor radialis longus, flexor carpi ulnaris, flexor carpi radialis, first dorsal interosseous; and in at least two of the following muscles: left/right gluteus maximus, left/right erector spinae, left/right quadratus lumborum,
  • Age > 16 years
  • Medically stable - cleared for surgery
  • Able and willing to take part in study

Exclusion Criteria:

  • Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant)
  • Other neurological conditions (multiple sclerosis, diabetes with peripheral nerve involvement)
  • History of coagulopathy, HIV, severe cardiopulmonary disease, severe bradycardia, severe autonomic dysreflexia, or chronic obstructive pulmonary disease.
  • Active untreated infection such as decubitus ulcer, urinary tract infection, pneumonia
  • Presence of other active implantable medical devices with unknown or untested interaction with the NNP implant
  • Active implantable medical device (AIMD) such as a pacemaker or defibrillator, with the exception of the implanted stimulator-telemeter (IST) or implanted receiver stimulator (IRS) systems developed by the Cleveland Functional Electrical Stimulation Center
  • Unhealed fractures that prevent functional use of arm or trunk
  • Less than six months post-injury (neuroprosthesis implantation delayed until criteria met)
  • Extensive upper extremity denervation (fewer than two stimulatable hand muscles and two stimulatable trunk muscles)
  • Involvement in other ongoing clinical studies that exclude concurrent until criteria met)
  • Disorder or condition that require MRI monitoring
  • Mechanical ventilator dependency
  • Progressive SCI In subjects who are undergoing bilateral implantation, subjects should not have a history of autonomic dysreflexia, hypertension, diabetes or any condition which requires frequent blood pressure monitoring or frequent venipuncture.
  • Adverse interaction between system components and typical electromagnetic (EM) sources in subject's home and work environments, including wheelchair or other active implantable devices.

Sites / Locations

  • MetroHealth Medical CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Intervention - implant neuroprosthesis

Arm Description

Receives implanted networked neuroprosthetic system for hand, arm, and trunk function. Undergoes functional training and assessment.

Outcomes

Primary Outcome Measures

Activities of Daily Living Abilities Test
Evaluation of ability to perform activities of daily living when using the neuroprosthesis compared to ability when the neuroprosthesis is turned off.

Secondary Outcome Measures

Grasp-Release Test
Ability to pick up, move, and release six standard objects.

Full Information

First Posted
December 29, 2014
Last Updated
May 15, 2023
Sponsor
Kevin Kilgore
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Case Western Reserve University, Congressionally Directed Medical Research Programs, FDA Orphan Products Division
search

1. Study Identification

Unique Protocol Identification Number
NCT02329652
Brief Title
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
Acronym
NNP-UE+T
Official Title
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 2014 (undefined)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
December 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Kevin Kilgore
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Case Western Reserve University, Congressionally Directed Medical Research Programs, FDA Orphan Products Division

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is to evaluate the use of a fully implanted device for providing hand function, reach, and trunk function to individuals with cervical spinal cord injury. Funding Sources: FDA OOPD NIH NINDS
Detailed Description
The goal of this project is to restore these multiple functions to these individuals through a comprehensive neuroprosthetic approach that addresses the overall needs of the individual. This approach involves all aspects of the implementation, including the implanted technology, the surgical installation, and the outcomes assessment through a coordinated team approach in order to maximize the functional independence gained by the individual. With this system, we propose that individuals who have a mid-cervical-level spinal cord injury will regain control over multiple functions, including grasp, reach, bed mobility, seated posture, restoration of an effective cough and bladder function. This ambitious and exciting goal is made possible by the culmination of our research and clinical deployment of neuroprosthetic systems for spinal cord injured subjects over the past 30 years. We anticipate that this system will not only provide increased independence in each of the targeted body functions, but will provide enough of an overall benefit to demonstrate significant improvements in quality of life and health outcomes. In clinical feasibility studies with spinal cord injured subjects, our clinical research teams have demonstrated the control of bilateral hand function, bed mobility, postural control, restoration of an effective cough, and bladder control using chronically implanted neuroprostheses. Outcomes from each clinical study demonstrate that each system provides increased functional independence to the individual. Initially, only a single type of implanted system was implemented in any one individual, resulting in restoration of a single bodily function. Thus, it has been necessary for subjects to choose between available functions and select only one, despite the fact that each subject had multiple disabilities. In the past few years, we have progressed to implementing a few subjects with more than one system, such as providing both hand function and trunk stability. However, the fundamental limitation of the current approach has been technological; i.e. each implanted system is completely independent (both technically and programmatically), requiring separate technology to be developed for each function, and these systems are implemented by separate teams in separate surgical procedures. Thus, to this point, it has not been possible to address each individual's comprehensive needs and tailor an overall approach that maximizes their functional gains. The proposed approach depends on the availability of a foundational platform technology that is capable of meeting our broad specifications. We have now achieved this milestone under separate funding, creating a revolutionary new implantable neuroprosthetic technology that is fully capable of providing the necessary technological base for our proposed research. This system, the Networked Neuroprosthetic System (NNPS), is a modular, scalable, and configurable network of fully implanted, networked modules capable of meeting or exceeding the needs of all of these neuroprosthetic applications. The NNPS provides a foundation which enables efficient technical refinements that optimize implementation of the system for each targeted application. The NNPS technology is currently operational and is undergoing fabrication and testing in preparation for final pre-clinical studies and human implantation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Spinal Cord Injury at C5-C7 Level, Spinal Cord Injury Cervical, Spinal Cord Injury at C5-C7 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Incomplete Lesion
Keywords
Neuroprosthesis, Functional Electrical Stimulation, Grasp, Posture, Standing, Function, Recovery, Device, Stimulation, Implant, Reach, Independence, Activities of Daily Living

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention - implant neuroprosthesis
Arm Type
Experimental
Arm Description
Receives implanted networked neuroprosthetic system for hand, arm, and trunk function. Undergoes functional training and assessment.
Intervention Type
Device
Intervention Name(s)
Networked Neuroprosthetic System for Grasp and Trunk
Intervention Description
Receive implanted networked neuroprosthesis
Primary Outcome Measure Information:
Title
Activities of Daily Living Abilities Test
Description
Evaluation of ability to perform activities of daily living when using the neuroprosthesis compared to ability when the neuroprosthesis is turned off.
Time Frame
Three months post-implant
Secondary Outcome Measure Information:
Title
Grasp-Release Test
Description
Ability to pick up, move, and release six standard objects.
Time Frame
Pre-implant and three months post-implant

10. Eligibility

Sex
All
Minimum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of cervical level spinal cord injury, either complete or incomplete; International Standards for Neurological Classification of Spinal Cord Injury (INCSCI) motor level of C4 through C8; American Spinal Injury Impairment Scale (AIS) grade A, B, C, or D; six months or more post-injury Biceps/brachialis/brachioradialis strength of 2/5 or higher on Manual Muscle Test Peripheral nerve innervation to upper extremity and trunk muscles, including a grade 3/5 or higher stimulated strength (Manual Muscle Test) in at least two of the following muscles in one arm: adductor pollicis, abductor pollicis brevis, flexor pollicis longus, extensor pollicis longus, extensor digitorum communis, flexor digitorum superficialis, flexor digitorum profundus, pronator quadratus, extensor carpi ulnaris, extensor carpi radialis brevis, extensor radialis longus, flexor carpi ulnaris, flexor carpi radialis, first dorsal interosseous; and in at least two of the following muscles: left/right gluteus maximus, left/right erector spinae, left/right quadratus lumborum, Age > 16 years Medically stable - cleared for surgery Able and willing to take part in study Exclusion Criteria: Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant) Other neurological conditions (multiple sclerosis, diabetes with peripheral nerve involvement) History of coagulopathy, HIV, severe cardiopulmonary disease, severe bradycardia, severe autonomic dysreflexia, or chronic obstructive pulmonary disease. Active untreated infection such as decubitus ulcer, urinary tract infection, pneumonia Presence of other active implantable medical devices with unknown or untested interaction with the NNP implant Active implantable medical device (AIMD) such as a pacemaker or defibrillator, with the exception of the implanted stimulator-telemeter (IST) or implanted receiver stimulator (IRS) systems developed by the Cleveland Functional Electrical Stimulation Center Unhealed fractures that prevent functional use of arm or trunk Less than six months post-injury (neuroprosthesis implantation delayed until criteria met) Extensive upper extremity denervation (fewer than two stimulatable hand muscles and two stimulatable trunk muscles) Involvement in other ongoing clinical studies that exclude concurrent until criteria met) Disorder or condition that require MRI monitoring Mechanical ventilator dependency Progressive SCI In subjects who are undergoing bilateral implantation, subjects should not have a history of autonomic dysreflexia, hypertension, diabetes or any condition which requires frequent blood pressure monitoring or frequent venipuncture. Adverse interaction between system components and typical electromagnetic (EM) sources in subject's home and work environments, including wheelchair or other active implantable devices.
Facility Information:
Facility Name
MetroHealth Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kevin L Kilgore, Ph.D.
Email
UE.FES.ClinicalTrials@gmail.com
First Name & Middle Initial & Last Name & Degree
Kevin L Kilgore, Ph.D.

12. IPD Sharing Statement

Citations:
PubMed Identifier
25064792
Citation
Ho CH, Triolo RJ, Elias AL, Kilgore KL, DiMarco AF, Bogie K, Vette AH, Audu ML, Kobetic R, Chang SR, Chan KM, Dukelow S, Bourbeau DJ, Brose SW, Gustafson KJ, Kiss ZH, Mushahwar VK. Functional electrical stimulation and spinal cord injury. Phys Med Rehabil Clin N Am. 2014 Aug;25(3):631-54, ix. doi: 10.1016/j.pmr.2014.05.001.
Results Reference
background
PubMed Identifier
23481680
Citation
Peckham PH, Kilgore KL. Challenges and opportunities in restoring function after paralysis. IEEE Trans Biomed Eng. 2013 Mar;60(3):602-9. doi: 10.1109/TBME.2013.2245128. Epub 2013 Mar 7.
Results Reference
background
PubMed Identifier
33729949
Citation
Makowski N, Campean A, Lambrecht J, Buckett J, Coburn J, Hart R, Miller M, Montague F, Crish T, Fu M, Kilgore K, Peckham PH, Smith B. Design and Testing of Stimulation and Myoelectric Recording Modules in an Implanted Distributed Neuroprosthetic System. IEEE Trans Biomed Circuits Syst. 2021 Apr;15(2):281-293. doi: 10.1109/TBCAS.2021.3066838. Epub 2021 May 25.
Results Reference
background
PubMed Identifier
18406958
Citation
Kilgore KL, Hoyen HA, Bryden AM, Hart RL, Keith MW, Peckham PH. An implanted upper-extremity neuroprosthesis using myoelectric control. J Hand Surg Am. 2008 Apr;33(4):539-50. doi: 10.1016/j.jhsa.2008.01.007.
Results Reference
result
Links:
URL
http://fescenter.org
Description
Cleveland Functional Electrical Stimulation Center
URL
http://restorefunction.org/
Description
Institute for Functional Restoration

Learn more about this trial

Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury

We'll reach out to this number within 24 hrs